Childhood cancer survivors: improving our practice today to reduce late, major surgical interventions tomorrow
Olga Nigro,Giovanna Gattuso,Giovanna Sironi,Marta Podda,Elisabetta Schiavello,Filippo Spreafico,Monica Terenziani
DOI: https://doi.org/10.21037/tp-23-417
2024-01-28
Translational Pediatrics
Abstract:Olga Nigro, Giovanna Gattuso, Giovanna Sironi, Marta Podda, Elisabetta Schiavello, Filippo Spreafico, Monica Terenziani Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Comment on: Dieffenbach BV, Murphy AJ, Liu Q, et al . Cumulative burden of late, major surgical intervention in survivors of childhood cancer: areport from the Childhood Cancer Survivor Study (CCSS) cohort. Lancet Oncol 2023;24:691-700. Keywords: Childhood cancer survivors (CCSs); late surgery; late effects Submitted Aug 03, 2023. Accepted for publication Dec 11, 2023. Published online Jan 05, 2024. doi: 10.21037/tp-23-417 Approximately 35,000 children and adolescents in Europe (1), and 450,000 in the US (2) are diagnosed with cancer every year. With more new technologies, advances in surgical techniques and innovative drug therapies being developed, childhood cancer survivors (CCSs) to date account for more than 80% of the patients treated for pediatric tumors (3-5). As these patients age and reach middle and late ages, they are at high risk of long-term side effects, including secondary cancers, and premature mortality (6). Recently, Dieffenbach et al. (7), analyzing data from the Childhood Cancer Survivor Study (CCSS, retrospective cohort study with longitudinal prospective follow-up of 25,656 5-year survivors of childhood cancer, who were diagnosed between 1970 and 1999, and matched with a group of 5,045 siblings), conducted a full examination of the associations between specific childhood cancer treatments and the burden of late surgical interventions. The authors observed a significant burden of late major surgical interventions: cardiovascular, spine, endocrine, central nervous system (CNS), respiratory, genitourinary, gastrointestinal, musculoskeletal, head and neck, breast interventions. The rate of these interventions was higher compared with that of their siblings (7) and these happened at a younger age (more than 10 year earlier than in the comparison group). The authors reported detailed risk categories. The risk of cumulative burden of major surgical interventions was higher in female versus male survivors, in those diagnosed in the 1990s versus those diagnosed on the 1970s, in those treated with locoregional surgery or radiotherapy, and in Hodgkin lymphoma and bone sarcoma patients (7). Surgery plays a fundamental role in the treatment of childhood cancer, also in the management of long-term sequelae (8), and the result of high cumulative late major interventions was expected due to these reasons. Treatment of secondary malignancies, bowel obstruction after surgical adhesions or abdominal radiotherapy, the shunt re-placement or revision in CNS survivors, correction of spinal deformity subsequent to radiotherapy or laminectomy, many limb salvage procedures, prosthetic substitutions, complications of amputations, and surgical treatment of osteonecrosis are some of the long lists of these late surgical interventions. The greatest merit of this work (7) is the detailed information available, to underline the extent of the issue (28,202 surgical intervention versus 4,110 in the siblings' cohort), which had been poorly quantified up to this point. When comparing data from survivors treated in the 1970s and those treated in the 1990s, an increasing cumulative burden of late major surgery emerges in the more recent group; this is probably due to an increased number of survivors of high-risk disease who underwent intense multimodal therapy, with subsequent occurrence of late, treatment-related complications (7). Moreover, Dieffenbach et al. shows how the cumulative burden of major surgical interventions is higher among female (versus male) survivors (7-12). Overall, female survivors were more frequently submitted to surgeries regarding breast, endocrine and cardiovascular systems, especially among those with Hodgkin's lymphoma [this is true for all cancer diagnoses except acute lymphocytic/lymphoblastic leukemia (ALL), soft tissue sarcomas, and Ewing sarcoma]. Data for early menopause was not available in these series, but it is well recognized that early menopause increases the risk of comorbidities such as cardiovascular disease and osteoporosis, and could be a cause of further late surgeries in female survivors. It was confirmed that women CCSs were particularly at risk for poor physical quality of life (QoL) (9), and in German female survivors, the worst QoL was described in all domains of the EORTC QLQ-C0, when compared to general population (10). The patients suffering most from the burden of major surgical interventions were survivors of Hodgkin's lymphoma, Ewing sarcoma and osteosarcoma (7). The development of new techniques and the knowledge acquired on late effects is expected to translate into a future lesser burden, particularly in selected groups of patients. In recent years, some tre -Abstract Truncated-
pediatrics